Compare GDS & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDS | PRGO |
|---|---|---|
| Founded | 2001 | 1887 |
| Country | China | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 2.0B |
| IPO Year | 2016 | 2013 |
| Metric | GDS | PRGO |
|---|---|---|
| Price | $30.64 | $13.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $45.27 | $19.33 |
| AVG Volume (30 Days) | 1.6M | ★ 2.4M |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | $12.93 | N/A |
| Revenue Next Year | $13.27 | $1.02 |
| P/E Ratio | $52.69 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.97 | $9.23 |
| 52 Week High | $48.61 | $22.65 |
| Indicator | GDS | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 51.41 |
| Support Level | $30.79 | $13.58 |
| Resistance Level | $34.06 | $13.89 |
| Average True Range (ATR) | 1.15 | 0.58 |
| MACD | -0.14 | -0.15 |
| Stochastic Oscillator | 18.93 | 10.17 |
GDS Holdings started as an IT service provider in 2001, then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates, and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China, and it has also started expanding into Southeast Asia via the now 23% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.